Science Explorer Back to mapMap
Discussion
Researcher · Leo Pharma (Denmark) · Denmark

Scilla Latini

Scilla Latini publishes mostly in Molecular Biology, Oncology and Cancer Research, on topics such as Cancer therapeutics and mechanisms, Vitamin D Research Studies and Cancer, Hypoxia, and Metabolism.

OpenAlex
World rank
#4,305,286
of 7,710,434 ranked researchers
Rank in Denmark
#30,303
of 43,819
Works
17
Citations
861
Citations per work
50.6
h-index
11
i10-index 11Top 71% in Molecular Biology
Scilla Latini

What does Scilla Latini research?

Scilla Latini's work is mostly in Biochemistry, Genetics and Molecular Biology (35%), Medicine (20%), Immunology and Microbiology (6%).

Life Sciences: 7 works · 41.3% of their workBiochemistry, Genetics and Molecular Biology: 6 works · 34.8% of their workMolecular Biology: 4 works · 26.1% of their workCancer Research: 1 works · 8.7% of their workImmunology and Microbiology: 1 works · 6.5% of their workImmunology: 1 works · 6.5% of their workEverything else: 6 works · 32.7% of their workHealth Sciences: 3 works · 19.5% of their workMedicine: 3 works · 19.5% of their workOncology: 2 works · 13.0% of their workPathology and Forensic Medicine: 1 works · 6.5% of their workPhysical Sciences: 1 works · 6.5% of their workChemistry: 1 works · 6.5% of their workOrganic Chemistry: 1 works · 6.5% of their workTHEIR WORKScilla Latini17works
Life Sciences41%Physical Sciences6%Health Sciences20%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology634.8%
    2. Immunology and Microbiology16.5%
  2. Everything else632.7%
    1. Medicine319.5%
    1. Chemistry16.5%
  1. 1Molecular Biology26% of their works
  2. 2Oncology13% of their works
  3. 3Cancer Research9% of their works
  4. 4Pathology and Forensic Medicine6% of their works
  5. 5Organic Chemistry6% of their works
  6. 6Immunology6% of their works

Research topics

Which keywords describe Scilla Latini's research?

The keywords of their largest research topics: Cancer, DNA, Topoisomerases, Deficiency, Vitamin D, Aneurysmal Subarachnoid Hemorrhage, ATP-dependent Transporters and Chemistry.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Cancer42 topics
  2. DNA41 topic
  3. Topoisomerases41 topic
  4. Deficiency31 topic
  5. Vitamin D31 topic
  6. ATP-dependent Transporters21 topic
  7. Aneurysmal Subarachnoid Hemorrhage21 topic
  8. Chemistry21 topic
  9. HIF-121 topic
  10. Intracranial Aneurysms21 topic
  11. Multidrug Resistance21 topic
  12. Vanadium21 topic
  13. Warburg Effect21 topic
  14. Matrix Metalloproteinases11 topic
  15. NF-?B11 topic
  16. Signaling11 topic
  17. Tissue Inhibitors of Metalloproteinases11 topic

Where does Scilla Latini work?

Scilla Latini's main affiliation in the publication record is Leo Pharma (Denmark), Denmark.

How many publications and citations does Scilla Latini have?

OpenAlex counts 17 works and 861 citations for Scilla Latini, an h-index of 11, ranking #4,305,286 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Scilla Latini. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.